French study checks how well a new drug combo works for rare lung cancer
Knowledge-focused
Completed
This study looked back at medical records of 204 French adults with an aggressive lung cancer called malignant pleural mesothelioma that could not be removed by surgery. All patients received a combination of two immunotherapy drugs (nivolumab and ipilimumab) through an early acc…
Sponsor: Groupe Francais De Pneumo-Cancerologie • Aim: Knowledge-focused
Last updated Jun 17, 2026 12:10 UTC